Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.

Kato-Hayashi H, Niwa T, Ohata K, Harada S, Matsumoto T, Kitagawa J, Tsurumi H, Suzuki A.

J Clin Pharm Ther. 2019 Dec;44(6):888-894. doi: 10.1111/jcpt.13011. Epub 2019 Aug 1.

PMID:
31373043
2.

High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A.

Med Oncol. 2019 Jun 3;36(7):63. doi: 10.1007/s12032-019-1288-7.

PMID:
31161433
3.

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.

Yamada Y, Fujii H, Watanabe D, Kato-Hayashi H, Ohata K, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Shimizu M, Suzuki A.

Cancers (Basel). 2018 Nov 16;10(11). pii: E454. doi: 10.3390/cancers10110454.

4.

Gastrointestinal bleeding associated with chronic excessive use overdosing with topical ketoprofen patch in elderly patient.

Hirose S, Matsuura K, Kato-Hayashi H, Suzuki A, Ohata K, Kobayashi R, Ibuka T, Araki H, Shimizu M, Itoh Y.

Scand J Gastroenterol. 2018 Jan;53(1):120-123. doi: 10.1080/00365521.2017.1390602. Epub 2017 Oct 18.

PMID:
29043859
5.

Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma.

Hayashi H, Suzuki A, Ohata K, Ishihara M, Kubota Y, Kobayashi R, Shibata Y, Nakamura H, Nakamura N, Kitagawa J, Tsurumi H, Shimizu M, Itoh Y.

Biol Pharm Bull. 2017;40(5):698-702. doi: 10.1248/bpb.b16-01001.

Supplemental Content

Loading ...
Support Center